Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents
Year: 2010
Type: article
Source: Investigational New Drugs
Authors: Margaret E. Macy, Deborah DeRyckere, Lia Gore
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: AstraZeneca, National Cancer Institute
OpenAlex ID: W1991753968
